FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations - FDA Press Releases

Today, the FDA authorized marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next generation sequencing (NGS) technology. It is the first HIV drug resistance assay that uses NGS that the FDA has authorized for marketing in the U.S.

from FDA Press Releases RSS Feed https://ift.tt/32lvYe8
via IFTTT